StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
RMTI

Rockwell Medical, Inc.

RMTI Nasdaq Pharmaceutical Preparations EDGAR ↗
$7.23
+0.04 +0.56%

Key statistics

from XBRL data in SEC filings
Market cap
$285M
Revenue (TTM)
$67.7M
Net income (TTM)
-$5.40M
EPS (TTM)
$-0.15
P/E ratio
Dividend yield
Free cash flow
-$1.20M
Cash
$9.61M
Total assets
$57.4M
Gross margin
17.1%
52-week range
$4.89 – $21.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 20, 2026 8-K Modified rights of security holders; Amended charter or bylaws Jun 29, 2026 8-K Shareholder vote results Jun 15, 2026 8-K Delisting notice or listing-rule failure May 8, 2026 8-K Regulation FD disclosure May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Regulation FD disclosure Mar 26, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Results of operations (earnings release) Jan 20, 2026 8-K Other events Jan 5, 2026 8-K Director or officer change Nov 18, 2025 8-K Regulation FD disclosure Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Director or officer change Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Shareholder vote results May 20, 2025 8-K Regulation FD disclosure May 12, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Regulation FD disclosure Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Director or officer change Dec 12, 2024 8-K Other events Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Regulation FD disclosure Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Aug 8, 2024 8-K Entered a material agreement; Regulation FD disclosure Jul 15, 2024 8-K Shareholder vote results May 23, 2024 8-K Regulation FD disclosure May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024